Somerset Group LLC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 277 filers reported holding GW PHARMACEUTICALS PLC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
Somerset Group LLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$360,000
-99.8%
1,660
-11.9%
0.27%
+19.8%
Q2 2020$231,327,000
+113295.6%
1,885
-3.5%
0.23%
+27.5%
Q4 2019$204,000
-79.6%
1,954
-77.5%
0.18%
-79.1%
Q3 2019$999,000
+10.3%
8,689
+65.4%
0.85%
+10.7%
Q2 2019$906,0005,2530.77%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q3 2020
NameSharesValueWeighting ↓
Lamond Capital Partners LLC 134,230$9,085,0005.95%
VHCP Management, LLC 311,853$21,106,0005.81%
Iguana Healthcare Management, LLC 60,000$4,061,0001.96%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 366,187$24,784,0000.95%
ACUTA CAPITAL PARTNERS, LLC 20,000$1,354,0000.92%
United Asset Strategies, Inc. 14,278$966,0000.41%
PRUDENTIAL PLC 823,408$55,728,0000.24%
Rock Springs Capital Management LP 28,000$1,895,0000.22%
CLOUGH CAPITAL PARTNERS L P 84,600$5,726,0000.20%
Eventide Asset Management 25,000$1,692,0000.18%
View complete list of GW PHARMACEUTICALS PLC shareholders